Krystal Biotech, Inc. (BIT:1KRYS)
162.75
0.00 (0.00%)
Last updated: Oct 31, 2025, 9:00 AM CET
Krystal Biotech Revenue
Krystal Biotech had revenue of $97.80M USD in the quarter ending September 30, 2025, with 16.65% growth. This brings the company's revenue in the last twelve months to $373.16M, up 54.51% year-over-year. In the year 2024, Krystal Biotech had annual revenue of $290.52M with 473.02% growth.
Revenue (ttm)
$373.16M
Revenue Growth
+54.51%
P/S Ratio
16.20
Revenue / Employee
$1.36M
Employees
275
Market Cap
4.96B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 290.52M | 239.82M | 473.02% |
| Dec 31, 2023 | 50.70M | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Stellantis | 146.12B |
| Eni S.p.A. | 86.56B |
| Enel SpA | 77.79B |
| Assicurazioni Generali | 56.79B |
| Intesa Sanpaolo | 25.38B |
| UniCredit | 24.85B |
| Prysmian | 19.85B |
| Leonardo S.p.a. | 18.70B |